Literature DB >> 31016944

[Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma].

Wanting Hou1, Qiulin Tang2, Feng Bi3.   

Abstract

To evaluate the differential expression profiles of the lncRNAs, miRNAs, mRNAs and ceRNAs, and their implication in the prognosis in clear cell renal cell carcinoma (CCRCC), the large sample genomics analysis technologies were used in this study. The RNA and miRNA sequencing data of CCRCC were obtained from The Cancer Genome Atlas (TCGA) database, and R software was used for gene expression analysis and survival analysis. Cytoscape software was used to construct the ceRNA network. The results showed that a total of 1 570 lncRNAs, 54 miRNAs, and 17 mRNAs were differentially expressed in CCRCC, and most of their expression levels were up-regulated (false discovery rate < 0.01 and absolute log fold change > 2). The ceRNA regulatory network showed the interaction between 89 differentially expressed lncRNAs and 9 differentially expressed miRNAs. Further survival analysis revealed that 38 lncRNAs (including COL18A1-AS1, TCL6, LINC00475, UCA1, WT1-AS, HOTTIP, PVT1, etc.) and 2 miRNAs (including miR-21 and miR-155) were correlated with the overall survival time of CCRCC ( P < 0.05). Together, this study provided us several new evidences for the targeted therapy and prognosis assessment of CCRCC.

Entities:  

Keywords:  The Cancer Genome Atlas; clear cell renal cell carcinoma; competing endogenous RNA; long noncoding RNA; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31016944     DOI: 10.7507/1001-5515.201801057

Source DB:  PubMed          Journal:  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi        ISSN: 1001-5515


  4 in total

1.  Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis.

Authors:  Yuenan Liu; Jun Wang; Yi Shou; Wenjie Xu; Ziwei Huang; Jiaju Xu; Kailei Chen; Jingchong Liu; Di Liu; Huageng Liang; Hongmei Yang; Xiaoping Zhang
Journal:  Cell Death Dis       Date:  2022-07-04       Impact factor: 9.685

2.  A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.

Authors:  Priyanka Kulkarni; Pritha Dasgupta; Yutaka Hashimoto; Marisa Shiina; Varahram Shahryari; Z Laura Tabatabai; Soichiro Yamamura; Yuichiro Tanaka; Sharanjot Saini; Rajvir Dahiya; Shahana Majid
Journal:  Cancer Res       Date:  2021-01-26       Impact factor: 13.312

3.  Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients.

Authors:  Yu Zhang; Qingjian Ye; Junxian He; Peigen Chen; Jing Wan; Jing Li; Yuebo Yang; Xiaomao Li
Journal:  Biomed Res Int       Date:  2020-02-14       Impact factor: 3.411

4.  A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma.

Authors:  Yarong Yang; Wenjuan Hua; Mei Zeng; Liling Yu; Baijun Zhang; Liming Wen
Journal:  Open Med (Wars)       Date:  2021-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.